A clinical study of MK-1045 in people with lupus or rheumatoid arthritis (MK-1045-004)
MK-1045-004
Phase 1 other active
Quick answer
A clinical study of MK-1045 in people with lupus or rheumatoid arthritis (MK-1045-004) for Systemic lupus erythematosus, Rheumatoid arthritis is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Systemic lupus erythematosus, Rheumatoid arthritis
- Phase
- Phase 1
- Modality
- other
- Status
- active